NZ286432A - Pharmaceutical compositions comprising 3-substituted-2-oxoindole-carboxamide derivatives and method of inhibition by photodecomposition thereof - Google Patents
Pharmaceutical compositions comprising 3-substituted-2-oxoindole-carboxamide derivatives and method of inhibition by photodecomposition thereofInfo
- Publication number
- NZ286432A NZ286432A NZ286432A NZ28643296A NZ286432A NZ 286432 A NZ286432 A NZ 286432A NZ 286432 A NZ286432 A NZ 286432A NZ 28643296 A NZ28643296 A NZ 28643296A NZ 286432 A NZ286432 A NZ 286432A
- Authority
- NZ
- New Zealand
- Prior art keywords
- red
- compound
- light
- yellow
- lake
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polymerisation Methods In General (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB1995/000287 WO1996033701A1 (en) | 1995-04-24 | 1995-04-24 | Inhibiting photodecomposition of 3-substituted-2-oxindoles |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ286432A true NZ286432A (en) | 1998-05-27 |
Family
ID=36997502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ286432A NZ286432A (en) | 1995-04-24 | 1996-04-23 | Pharmaceutical compositions comprising 3-substituted-2-oxoindole-carboxamide derivatives and method of inhibition by photodecomposition thereof |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP0827399A1 (is) |
JP (1) | JPH10506635A (is) |
KR (1) | KR100189585B1 (is) |
CN (1) | CN1053667C (is) |
AP (1) | AP607A (is) |
AR (1) | AR002728A1 (is) |
AU (1) | AU692378B2 (is) |
BG (1) | BG100531A (is) |
BR (1) | BR9602024A (is) |
CO (1) | CO4700418A1 (is) |
FI (1) | FI973988A0 (is) |
HR (1) | HRP960194A2 (is) |
HU (1) | HU216544B (is) |
IL (1) | IL117969A0 (is) |
IS (1) | IS4339A (is) |
MA (1) | MA23848A1 (is) |
NO (1) | NO961622L (is) |
NZ (1) | NZ286432A (is) |
OA (1) | OA10286A (is) |
PE (1) | PE34397A1 (is) |
RO (1) | RO113305B1 (is) |
RU (1) | RU2109510C1 (is) |
SG (1) | SG64924A1 (is) |
SI (1) | SI9600133A (is) |
SK (1) | SK51296A3 (is) |
TR (1) | TR199600300A2 (is) |
UA (1) | UA42739C2 (is) |
WO (1) | WO1996033701A1 (is) |
YU (1) | YU25096A (is) |
ZA (1) | ZA963210B (is) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019132959A1 (en) | 2017-12-29 | 2019-07-04 | Kraft Foods Group Brands Llc | Improved oxidative stability of oil-in-water emulsions using natural stabilizers |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT59592A (en) * | 1990-07-20 | 1992-06-29 | Egyt Gyogyszervegyeszeti Gyar | Process for the preparation of solid medical products |
TW438798B (en) * | 1992-10-07 | 2001-06-07 | Pfizer | 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
-
1995
- 1995-04-24 UA UA96041574A patent/UA42739C2/uk unknown
- 1995-04-24 SK SK512-96A patent/SK51296A3/sk unknown
- 1995-04-24 RU RU96108120A patent/RU2109510C1/ru active
- 1995-04-24 WO PCT/IB1995/000287 patent/WO1996033701A1/en not_active Application Discontinuation
- 1995-04-24 EP EP95914494A patent/EP0827399A1/en not_active Ceased
- 1995-04-24 JP JP8532298A patent/JPH10506635A/ja active Pending
-
1996
- 1996-03-07 AP APAP/P/1996/000787A patent/AP607A/en active
- 1996-03-28 AR ARP960101956A patent/AR002728A1/es unknown
- 1996-04-10 TR TR96/00300A patent/TR199600300A2/xx unknown
- 1996-04-18 IL IL11796996A patent/IL117969A0/xx unknown
- 1996-04-19 IS IS4339A patent/IS4339A/is unknown
- 1996-04-19 SG SG1996009306A patent/SG64924A1/en unknown
- 1996-04-22 CO CO96019210A patent/CO4700418A1/es unknown
- 1996-04-22 PE PE1996000275A patent/PE34397A1/es not_active Application Discontinuation
- 1996-04-22 RO RO96-00843A patent/RO113305B1/ro unknown
- 1996-04-22 CN CN96105084A patent/CN1053667C/zh not_active Expired - Fee Related
- 1996-04-23 BG BG100531A patent/BG100531A/xx unknown
- 1996-04-23 ZA ZA9603210A patent/ZA963210B/xx unknown
- 1996-04-23 NZ NZ286432A patent/NZ286432A/en unknown
- 1996-04-23 HU HU9601057A patent/HU216544B/hu not_active IP Right Cessation
- 1996-04-23 YU YU25096A patent/YU25096A/sh unknown
- 1996-04-23 MA MA24209A patent/MA23848A1/fr unknown
- 1996-04-23 AU AU50851/96A patent/AU692378B2/en not_active Ceased
- 1996-04-23 HR HRPCT/IB95/00287A patent/HRP960194A2/hr not_active Application Discontinuation
- 1996-04-23 NO NO961622A patent/NO961622L/no unknown
- 1996-04-23 KR KR1019960012356A patent/KR100189585B1/ko not_active IP Right Cessation
- 1996-04-24 OA OA60821A patent/OA10286A/en unknown
- 1996-04-24 BR BR9602024A patent/BR9602024A/pt active Search and Examination
- 1996-04-24 SI SI9600133A patent/SI9600133A/sl not_active IP Right Cessation
-
1997
- 1997-10-17 FI FI973988A patent/FI973988A0/fi unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI92904C (fi) | Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi | |
RU2357757C2 (ru) | Твердый препарат | |
SK74095A3 (en) | Pharmaceutical mixture with antidepressive activity | |
JPH10504557A (ja) | イブプロフェンおよびコデイン含有の改良された医薬処方 | |
NZ270748A (en) | Sustained release dosage form of alfuzosin hydrochloride coated with a ph-dissolution dependent polymer | |
CA1069441A (en) | Pharmaceutical composition containing 2,1,3-benzothiazole | |
AP607A (en) | Inhibiting photodecomposition of 3-substituted-2-oxindoles. | |
IL105468A (en) | Pharmaceutical preparations containing agonists for TH5-1-like receptors for rectal administration | |
NL8002041A (nl) | Werkwijze voor het bereiden van een analgetisch en myotonolytisch geneesmiddel. | |
US4188393A (en) | Treating spastic conditions or relaxing muscles | |
CA2216931A1 (en) | Inhibiting photodecomposition of 3-substituted-2-oxindoles | |
AU780341B2 (en) | Novel pharmaceutical combination with analgesic action containing paracetamol and buspirone | |
WO2002015899A1 (en) | Combination therapy for the treatment of migraine | |
NO932382L (no) | Heterocykliske forbindelser | |
US4145421A (en) | Treating spastic conditions | |
CA2367402C (en) | Stable pharmaceutical dosage form for paroxetine anhydrate | |
AU620658B2 (en) | Memory-enhancing compositions containing dioxopiperidine derivatives | |
CA2232559A1 (en) | Method for treating a tic disorder | |
AU726758B2 (en) | Melatonin derivatives for use in treating desynchronization disorders | |
JPS6323969B2 (is) | ||
MXPA97008155A (en) | Inhibition of the photo-composition of 2-oxindoles 3-substitute | |
MXPA00004573A (en) | Novel oral dosage form for carvedilol |